N
NewAmsterdam Pharma Company NV
F:KH6
NewAmsterdam Pharma Company NV
F:KH6
Price:
25
EUR
3.31%
Market Closed
Market Cap:
€119.6B
Income Statement
Earnings Waterfall
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Income Statement
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Currency: EUR
| Jun-2022 | Sep-2022 | Dec-2022 | Jun-2023 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
98
N/A
|
107
+10%
|
|
| Operating Income | |||||
| Operating Expenses |
(3)
|
(5)
|
(101)
|
(254)
|
|
| Selling, General & Administrative |
(3)
|
(5)
|
(14)
|
(30)
|
|
| Research & Development |
0
|
0
|
(82)
|
(155)
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
(5)
|
(69)
|
|
| Operating Income |
(3)
N/A
|
(5)
-61%
|
(4)
+23%
|
(147)
-3 629%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
5
|
0
|
(10)
|
(11)
|
|
| Non-Reccuring Items |
0
|
0
|
(64)
|
0
|
|
| Pre-Tax Income |
3
N/A
|
(4)
N/A
|
(78)
-2 045%
|
(158)
-102%
|
|
| Net Income | |||||
| Tax Provision |
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
3
|
(4)
|
(78)
|
(158)
|
|
| Net Income (Common) |
3
N/A
|
(4)
N/A
|
(78)
-2 045%
|
(158)
-102%
|
|
| EPS (Diluted) |
0.16
N/A
|
-0.21
N/A
|
-0.95
-352%
|
-1.92
-102%
|
|
Switch to:
Switch to:
See Also
Discover More
